ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 986

Fucosylated Tumor Necrosis Factor α Is Expressed in Rheumatoid Arthritis Synovial Tissues and Is Involved in Monocyte Adhesion

Takeo Isozaki, Shinichiro Nishimi and Tsuyoshi Kasama, Div of Rheumatology, Showa University School of Med, Shinagawa-ku Tokyo, Japan

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Adhesion molecules, glycoproteins and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, October 22, 2018

Title: Cytokines and Cell Trafficking Poster

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Glycosylation has been reported to associate with tumor invasion and metastasis. Fucosylation is involved in the biological functions of adhesion molecules and growth factor receptors. In regards to arthritis, we have previously reported that glycan in rheumatoid arthritis (RA) serum was higher than that in normal subjects serum. However, a direct role for fucosylated cytokines in RA has not been demonstrated. Here, we examined fucosylated tumor necrosis factor (TNF)-α was expressed in RA synovial tissues, as TNF-α is a central cytokine in RA pathology and the role it plays in monocyte adhesion.

Methods:

To determine if the fucosylated TNF-α was expressed in RA and osteoarthritis (OA) synovial tissues, we performed immunofluorescence. In order to indicate that the expression of fucosylated TNF-α was in RA synovial fluids, immunoprecipitation and lectin blotting were performed. 2-deoxy-D-galactose (2-dGal) is an analog of hexose that inhibits fucosylation. In addition, to clarify the mechanism of fucosylation in monocyte adhesion, human umbilical vein endothelial cells (HUVECs) were treated with 2-dGal (15 mM) for 5 days. THP-1 (human acute monocyte leukemia cell line) adhesion to 2-dGal treated or nontreated HUVEC was measured. Finally, to confirm which adhesion molecules were involved in fucosylation, cell surface ELISA was performed.

Results: Fucosylated TNF-α was expressed in RA synovial tissues. Hence, fucosylated TNF-α in RA synovial tissues was significantly highly expressed compared with that in OA synovial tissues. Fucosylated TNF-α in RA synovial fluids was also significantly higher compared with in OA synovial fluids. Fucosylated proteins in 2-dGal treated HUVECs were decreased compared with these in nontreated HUVECs. Adhesion of THP-1 cells to 2-dGal treated HUVECs in response to TNF-α was significantly decreased compared with nontreated HUVECs (adhesion index of THP-1 to HUVECs ± SEM; 1.2 ± 0.1 and 1.4 ± 0.1, p<0.05, respectively). In addition, intercellular adhesion molecule 1 (ICAM-1) on TNF-α stimulated 2-dGal treated HUVECs were decreased compared to nontreated HUVECs (fold change of ICAM-1 expressed ± SEM; 5.5 ± 0.2 and 9.0 ± 0.2, p<0.05, respectively).

Conclusion: Fucosylated TNF-α was expressed in RA synovium, and inhibition of fucosylation in ECs had less monocyte adhesion. These data indicate that cytokine fucosylation is involved with RA and plays a role in inflammation, suggest that targeting fucosylation may provide a method by which to decrease inflammation.


Disclosure: T. Isozaki, None; S. Nishimi, None; T. Kasama, None.

To cite this abstract in AMA style:

Isozaki T, Nishimi S, Kasama T. Fucosylated Tumor Necrosis Factor α Is Expressed in Rheumatoid Arthritis Synovial Tissues and Is Involved in Monocyte Adhesion [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/fucosylated-tumor-necrosis-factor-%ce%b1-is-expressed-in-rheumatoid-arthritis-synovial-tissues-and-is-involved-in-monocyte-adhesion/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/fucosylated-tumor-necrosis-factor-%ce%b1-is-expressed-in-rheumatoid-arthritis-synovial-tissues-and-is-involved-in-monocyte-adhesion/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology